Advertisement
Advertisement
LEGN
Legend Biotech Corporation - ADR
17.11
USDSponsored
+0.41
+2.43%
Feb 06, 15:59 UTC -5
Closed
After-Market
17.11
0.00
0.00%
LEGN Earnings Reports
Positive Surprise Ratio
LEGN beat 9 of 20 last estimates.
45%
Next Report
Date of Next Report
Mar 09, 2026
Estimate for Q4 25 (Revenue/ EPS)
$313.95M
/-$0.06
Implied change from Q3 25 (Revenue/ EPS)
+15.28%
/-72.73%
Implied change from Q4 24 (Revenue/ EPS)
+68.32%
/-140.00%
Legend Biotech Corporation - ADR earnings per share and revenue
On Nov 12, 2025, LEGN reported earnings of -0.22 USD per share (EPS) for Q3 25, missing the estimate of -0.08 USD, resulting in a -155.52% surprise. Revenue reached 272.33 million, compared to an expected 277.95 million, with a -2.02% difference. The market reacted with a -2.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 313.95 million USD, implying an decrease of -72.73% EPS, and increase of 15.28% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
FAQ
What were Legend Biotech Corporation - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Legend Biotech Corporation - ADR reported EPS of -$0.22, missing estimates by -155.52%, and revenue of $272.33M, -2.02% below expectations.
How did the market react to Legend Biotech Corporation - ADR's Q3 2025 earnings?
The stock price moved down -2.67%, changed from $32.03 before the earnings release to $31.18 the day after.
When is Legend Biotech Corporation - ADR expected to report next?
The next earning report is scheduled for Mar 09, 2026.
What are the forecasts for Legend Biotech Corporation - ADR's next earnings report?
Based on 18
analysts, Legend Biotech Corporation - ADR is expected to report EPS of -$0.06 and revenue of $313.95M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement